Key result
Surgical mitral valve repair remains the standard treatment for mitral regurgitation over newer transcatheter options.
This article provides a surgeon's perspective on the recent developments in transcatheter mitral valve repair compared to the standard surgical approach for mitral regurgitation.
Answers are grounded in this paper and cite their sources.
Continues to support surgical mitral valve repair as preferred for eligible patients; leaves open optimal integration of transcatheter options in prospective trials.
State-of-the-art treatment for mitral regurgitation (MR) has been and remains surgical mitral valve (MV) repair. Several transcatheter-based innovations however have been introduced to facilitate MV repair. This article aims to relate the recent developments in transcatheter MV repair to the current standard of MV surgery for treatment of MR from a surgeon's point of view.
No takes yet. Share an insight, caveat, or question.
Seeburger et al. (2010) studied this question. Surgical mitral valve repair remains the state-of-the-art standard treatment for mitral regurgitation despite recent developments in transcatheter-based innovations.
Synapse has enriched 10 related papers. Consider them for comparative context: